Abstract:The activation status can dictate the fate of an HIV-infected CD4+ T cell. Infected cells with a low level of activation remain latent and do not produce virus, while cells with a higher level of activation are more productive and thus likely to transfer more virions to uninfected cells during cell-to-cell transmission. How the activation status of infected cells affects HIV dynamics under antiretroviral therapy remains unclear. We develop a new mathematical model that structures the population of infected cells continuously according to their activation status. The effectiveness of antiretroviral drugs in blocking cell-to-cell viral transmission decreases as the level of activation of infected cells increases because the more virions are transferred from infected to uninfected cells during cell-to-cell transmission, the less effectively the treatment is able to inhibit the transmission. The basic reproduction number R_0 of the model is shown to determine the existence and stability of the equilibria. Using the principal spectral theory and comparison principle, we show that the infection-free equilibrium is locally and globally asymptotically stable when R_0 is less than one. By constructing Lyapunov functional, we prove that the infected equilibrium is globally asymptotically stable when R_0 is greater than one. Numerical investigation shows that even when treatment can completely block cell-free virus infection, virus can still persist due to cell-to-cell transmission. The random switch between infected cells with different activation levels can also contribute to the replenishment of the latent reservoir, which is considered as a major barrier to viral eradication. This study provides a new modeling framework to study the observations, such as the low viral load persistence, extremely slow decay of latently infected cells and transient viral load measurements above the detection limit, in HIV-infected patients during suppressive antiretroviral therapy.

Viral Dynamics of an HIV Model with Latent Infection Incorporating Antiretroviral Therapy

Mathematical analysis of an HIV model with latent reservoir, delayed CTL immune response and immune impairment

A Stochastic HIV Infection Model with Latent Infection and Antiretroviral Therapy

Viral dynamics of of a latent HIV infection model with Beddington-DeAngelis incidence function, B-cell immune response and multiple delays

Viral dynamics model with CTL immune response incorporating antiretroviral therapy

The Global Dynamics of HIV Latency Model Including Cell-to-Cell Viral Transmission

The Effects of Latent Infection on the Dynamics of HIV

Mathematical Analysis of an HIV Latent Infection Model Including Both Virus-to-cell Infection and Cell-to-cell Transmission.

Dynamics of a New HIV Model with the Activation Status of Infected Cells

Dynamic analysis of an HIV model with CTL immune response and logarithmic Ornstein–Uhlenbeck process

Virus Dynamics Model with Intracellular Delays and Immune Response.

Modeling virus-stimulated proliferation of CD4+ T-cell, cell-to-cell transmission and viral loss in HIV infection dynamics

Global Properties for a Class of Latent HIV Infection Dynamics Model with CTL Immune Response.

Viral Dynamics of an HTLV-I Infection Model with Intracellular Delay and CTL Immune Response Delay

An HIV Model with Age-Structured Latently Infected Cells.

Viral Dynamics of an HIV Stochastic Model with Cell-to-cell Infection, CTL Immune Response and Distributed Delays

Global Dynamics of A Viral Infection Model with Full Logistic Terms and Antivirus Treatments

An HIV Latent Infection Model with Cell-to-cell Transmission and Stochastic Perturbation

Analysis of an HIV Model with Immune Responses and Cell-to-Cell Transmission

Global stability for a delayed HIV reactivation model with latent infection and Beddington–DeAngelis incidence

Dynamics Analysis and Simulation of a Modified HIV Infection Model with a Saturated Infection Rate.